Abstract book - ESTRO meets Asia

Poster Viewing Quality management and verification (RTT) .................................................................(Abs. 89-94)

Symposium Global Impact of Radiotherapy in Oncology (GIRO) .......................................................(Abs. 95-97)

Teaching Lecture Volume effects, retreatment ......................................................................................(Abs. 98) Brachytherapy ......................................................................................................... (Abs. 99-101) High tech technologies ............................................................................................. (Abs. 102-103) Clinical manifestations of normal tissue damage ........................................................... (Abs. 104)

Symposium Thorax high tech ..................................................................................................... (Abs. 105-107)

Teaching Lecture Radiation carcinogenesis, prenatal, heritable ...............................................................(Abs. 108)

Proffered Papers Stimulating topics for discussion (RTT) . ...................................................................... (Abs. 109-115) CL4: Prostate .......................................................................................................... (Abs. 116-120)

Poster Viewing Stimulating topics for discussion (physics) . ................................................................. (Abs. 121-127)

SUNDAY 9 DECEMBER 2018

Round table/Debate Setting the scene: advocacy and education ................................................................. (Abs. 128-132) Advocacy initiatives and priorities in the global setting .................................................. (Abs. 133-137) Posters Clinical: Head and neck ............................................................................................ (Abs. 138-162) Clinical: CNS ........................................................................................................... (Abs. 163-174) Clinical: Haematology. ............................................................................................. (Abs. 175-178) Clinical: Breast........................................................................................................ (Abs. 179-200) Clinical: Lung.......................................................................................................... (Abs. 201-214) Clinical: Upper GI (oesophagus, stomach, pancreas, liver) ............................................. (Abs. 215-226) Clinical: Lower GI (colon, rectum, anus) ..................................................................... (Abs. 227-234) Clinical: Gynaecological (endometrium, cervix, vagina, vulva) ........................................ (Abs. 235-246) Clinical: Prostate ..................................................................................................... (Abs. 247-252) Clinical: Urology-non-prostate ................................................................................... (Abs. 253-257) Clinical: Paediatric tumours ....................................................................................... (Abs. 258-259) Clinical: Palliation .................................................................................................... (Abs. 260-262) Clinical: Elderly ....................................................................................................... (Abs. 263-265) Clinical: Health services research / health economics .................................................... (Abs. 267-268) Clinical: Communication ...........................................................................................(Abs. 269) Physics: From 2D to IMRT: technology, treatment planning, delivery and QA .................... (Abs. 271-284) Physics: IGRT, patient positioning and mobilisation....................................................... (Abs. 285) Physics: Dosimetry, audits and risk assessment ........................................................... (Abs. 286-291) Physics: Brachytherapy . ...........................................................................................(Abs. 292) Physics: Other . ....................................................................................................... (Abs. 293-298) Interdisciplinary: Professional Education and training.................................................... (Abs. 299-301) Radiobiology: Radiobiology of stem cells (cancer and normal tissue) ............................... (Abs. 302) Radiobiology: Radiobiology of particles and heavy ions .................................................. (Abs. 303-305) Radiobiology: Radiation-induced signalling pathways .................................................... (Abs. 306-309) Radiobiology: Immuno-radiobiology ........................................................................... (Abs. 310) Radiobiology: Miscellaneous ...................................................................................... (Abs. 311-313) RTT: Treatment verification .......................................................................................(Abs. 314)